Bio-Rad Laboratories, Inc. (BIO)
245.59
+2.08
(+0.85%)
USD |
NYSE |
May 14, 11:38
Bio-Rad Laboratories Cash from Investing (Quarterly) : -93.20M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies, Inc. | -93.00M |
| Bruker Corp. | -39.70M |
| Azenta, Inc. | -114.75M |
| Harvard Bioscience, Inc. | -0.62M |
| Revvity, Inc. | -78.27M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 108.10M |
| Cash from Financing (Quarterly) | -44.00M |
| Free Cash Flow | 357.20M |
| Free Cash Flow Per Share (Quarterly) | 2.897 |
| Free Cash Flow to Equity (Quarterly) | 85.20M |
| Free Cash Flow to Firm (Quarterly) | 87.50M |
| Free Cash Flow Yield | 5.38% |